CAR T-cells transduced with CCR2b, the dominant isoform of CCR2, showed improved tumor infiltration and tumor control in mouse models, including successfully crossing the blood-brain barrier to control brain metastases from NSCLC (183–185). The gene discussed is CCR2; the disease is neoplasm.